SCI时时刷

search
+
HCC genomic landscape in Chinese individuals
Researchers from the Chinese Liver Cancer Atlas project performed deep whole-genome sequencing of hepatocellular carcinoma...
Seladelpar in primary biliary cholangitis
In a phase III, double-blind, placebo-controlled trial, 193 patients with primary biliary cholangitis and an inadequate re...
Bacteriophages and host inflammation in IBD
Researchers analysed metagenomic data from 1,618 patients with inflammatory bowel disease (IBD) and 791 healthy individual...
Tackling sorbitol intolerance
Tackling sorbitol intolerance
Sorbitol, a poorly absorbable sweetener, is catabolized by gut microbiota, mainly Clostridia. Lee et al. now elucidate the...
New understanding of hepatobiliary MRI
New understanding of hepatobiliary MRI
Magnetic resonance imaging following injection of hepatobiliary contrast agents improves the detection of hepatocellular c...
Improving culturally safe engagement with sexual and gender minority populations
Cultural safety seeks to remediate health inequities through empowering marginalized and minoritized patient populations, ...
Publisher Correction: Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota–gut–brain axis
Authors and AffiliationsAPC Microbiome Ireland, University College Cork, Cork, IrelandMaría R. Aburto & John F. CryanD...
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
Bile acids regulate nutrient absorption and mitochondrial function, they establish and maintain gut microbial community co...
RET signalling controls gut motility
RET signalling controls gut motility
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
New options for late-line treatment of metastatic colorectal cancer
New options for late-line treatment of metastatic colorectal cancer
Metastatic colorectal cancer is a heterogeneous disease associated with poor patient outcomes. Although the past ...
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Overweight and obesity are characterized by excessive fat mass accumulation produced when energy intake exceeds energy exp...
Microbiota-based biomarkers and therapeutics for cancer management
Microbiota-based biomarkers and therapeutics for cancer management
New light is being shed on the interactions between the gut microbiome, cancer cell signalling and the host immune respons...
Tumour-associated macrophages and pancreatic cancer: an inflammatory loop
Tumour-associated macrophages and pancreatic cancer: an inflammatory loop
In a new study published in Nature, researchers have investigated the role of tumour-associated macrophages (TAMs) in panc...
Upgrading therapeutic ambitions and treatment outcomes
Upgrading therapeutic ambitions and treatment outcomes
Important studies published in 2023 outlined new agents and strategies for the management of inflammatory bowel disease. T...
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and c...
Elafibranor in primary biliary cholangitis
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for patients with localized pancrea...
Resmetirom safe for nonalcoholic fatty liver disease
A 52-week randomized, double-blind, placebo-controlled phase III trial (MAESTRO-NAFLD-1) evaluated the safety of resmetiro...
Risk of HCC in individuals of sub-Saharan ethnicity or descent with chronic hepatitis B in Europe
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
See the reality again in the field of liver transplantation
In 2023, we witnessed advances in allocation policies and marginal donors, including living donors. Key improvements inclu...
Amitriptyline as second-line treatment for IBS in primary care settings
Titrated low-dose amitriptyline (a tricyclic antidepressant) was superior to placebo as a second-line treatment for irrita...
Fresh perspectives on how to build, maintain and repair the ENS
Fresh perspectives on how to build, maintain and repair the ENS
Enteric nervous system function is essential for survival. Studies published in 2023 have provided important novel insight...
EASL SLD Summit 2023
In September 2023, Nature Reviews Gastroenterology & Hepatology attended the European Association for the Study of the...
No excess cancer risk for non-erosive disease
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
SMART cancer risk prediction
A new machine-learning (ML) tool outperforms all existing hepatocellular carcinoma risk prediction methods in patients wit...
A distinct CD103+Vγ4+ γδ T cell subset is linked to lesion healing and improved prognosis
A distinct CD103+Vγ4+ γδ T cell subset is linked to lesion healing and improved prognosis
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
Folate receptor-γ in MASH-related fibrosis
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
Innovation is needed to increase viral hepatitis testing globally
Innovation is needed to increase viral hepatitis testing globally
Innovative approaches to increase testing are needed to achieve the 2030 hepatitis B and hepatitis C elimination targets. ...
Implications of the evolving knowledge of the genetic architecture of MASLD
Implications of the evolving knowledge of the genetic architecture of MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) has a strong heritable component, and genome-wide associa...
Deciphering the different phases of preclinical inflammatory bowel disease
Deciphering the different phases of preclinical inflammatory bowel disease
Inflammatory bowel disease (IBD) is an immune-mediated inflammatory disease (IMID) of the gastrointestinal tract and inclu...
阅读更多
format_indent_increase